Regulatory Rapporteur July/August 2020 | MEMBERS |
An overview of the CMDv’s pilot part II harmonisation project | MEMBERS |
Managing the supply of unlicensed medicines to patients in the UK | MEMBERS |
ICH Q12: how it impacts the management of your CMC post-approval changes | MEMBERS |
Considerations for virtualising clinical trials in the midst of COVID-19 | MEMBERS |
Getting effective medicines to children in a timely manner - an interview with Koen Norga of EMA's Paediatric Committee | MEMBERS |